Search NaijaAgroNet

Monday, April 23, 2018

Novartis enters 5-year partnership on malaria elimination, votes USD100m

A five-year commitment to the fight against malaria has been entered by Novartis in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonwealth Heads of Government meeting, reports NaijaAgroNet.

The company, NaijaAgroNet gathered, also released new African research on progress and remaining challenges toward the 2030 malaria elimination targets, together with Elimination 8 and the KEMRI-Wellcome Trust program.

Over the next five years, as part of its commitment, Novartis will invest more than USD 100 million to advance research and development of next-generation treatments to combat emerging resistance to artemisinin and other currently used antimalarials. The company will also implement an equitable pricing strategy to maximize patient access in malaria-endemic countries when these new treatments become available. In order to contribute to the WHO’s target of reducing malaria-related child mortality by at least 90% by 2030, Novartis will further help expand access to pediatric antimalarials and implement healthcare system strengthening programs in 4 sub-Saharan countries.

“Resistance to treatment presents the biggest threat to the incredible progress that has been made in the fight against malaria in the past 20 years. We cannot afford to wait; this is why we are committing to advance the research and development of next-generation treatments,” said Vas Narasimhan, CEO of Novartis. “At the same time, we need to work to ensure that our innovation reaches those most in need, even those in the most remote locations.”

The R&D investment is meant to advance the Novartis malaria pipeline through 2023 and to complete a comprehensive global clinical trial program for our novel antimalarial drug candidates KAF156 and KAE609 (currently in Phase IIb and Phase IIa respectively [1]). Both are from new classes of medicines that were selected for their ability to treat malaria in different ways from current therapies. The investment also includes new uses of technology to identify areas where the malaria burden is greatest. This information could then be used to support capability- and capacity-building to establish future clinical trial sites, so the medicines can be evaluated in the populations where they are most needed.


Isaac Oyimah/GEE

... Linking agrobiz, sustainable environs, people & technology

1 comment:


  1. I want to give a big thanks to a great spell caster commonly known as DR TAKUTA for the great spiritual prayers he did in my life by bringing my ex-lover back to me after many months of breakup and loneliness. With this, I am convinced that you are sent to this word to rescue people from heartbreaks and also to help us get the solution to every relationship problem. for those of you out there who have one relationship problem or the other why not contact DR TAKUTA. that is the best place you can solve all your problems, including a lack of jobs and promotions, binding and marriage spells, divorce and attraction spells, good luck and lotto spells, fertility, and pregnancy spells, and also the business success and customer increase, winning court cases and many more. contact him at takutaspellalter@gmail.com or contact mobile contact +27788634102










































































    ReplyDelete

Share ur views here